Timing of Convalescent Plasma Treatment
The timing of convalescent plasma treatment is crucial when it comes to its effectiveness in treating patients. Research has shown that patients who receive convalescent plasma with a high titer within 44 hours of being admitted to the hospital experience the most significant reduction in mortality rates.
A study conducted on this topic revealed that patients who required a ventilator upon hospital admission did not experience any mortality benefit when they received high titer convalescent plasma more than 72 hours after being admitted.
Convalescent Plasma and Omicron
Effectiveness of Convalescent Plasma Against Omicron Variant
Prior to the dominance of the Omicron variant, researchers primarily conducted convalescent plasma studies on Sars-Cov-2 variants. However, recent research indicates that convalescent plasma is less effective against the Omicron variant compared to other variants.
A study conducted on patients infected with the Omicron variant revealed that convalescent plasma is only half as effective in combating Omicron as it is against the Beta variant.